Not exact matches
These risks and uncertainties
include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain
growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products,
including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize
cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products,
including Biktarvy; Gilead's ability to successfully commercialize its products,
including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates,
including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
The team confirmed that genetic «knockdown» of PRMT1 significantly impaired PDAC
cell growth in vitro through use of genetic editing tools,
including CRISPR and small hairpin RNA (shRNA).
Baylin says certain genes that control
cell growth get turned down periodically during certain stages of life,
including embryogenesis, when organisms are growing and developing rapidly.
The most common mutations, occurring in five of the women, occurred in genes
including ARID1A, PIK3CA, KRAS and PPP2R1A, all known for controlling
cell growth,
cell invasion and DNA damage repair.
Small populations of adult stem
cells with somewhat limited developmental potential are responsible for the body's ability to heal injuries and replace worn out
cells and tissues, and evidence is growing that rare cancer stem
cells are responsible for the uncontrolled
growth of some malignant tumors,
including glioblastoma.
IL - 15 is a
growth factor for certain kinds of white blood
cells including natural killer
cells and T
cells.
The Campàs lab is studying several of these questions,
including how limbs are built and how mechanical changes in tumors affect the behavior of malignant
cells and the
growth of the tumor.
By providing a woman's family history of these cancers,
including the ages they were diagnosed, the programs calculate a probability that the patient carries a harmful mutation in BRCA1 or BRCA2 (genes involved in controlling malignant
cell growth).
Others
include transplanting so - called Schwann
cells from peripheral nerves, using
growth factors to stimulate nerve
growth, and boosting the immune system in the damaged area (New Scientist magazine, 14 August 1999, p 36).
Cyclin D is synthesized during the first stage of
cell replication and is believed to help drive the complex, multi-stage process,
including interaction with the retinoblastoma (Rb) protein, whose function is to prevent excessive
cell growth by inhibiting
cell cycle progression until a
cell is ready to divide.
genes, the team has shown that B. theta helps guide the normal development and functioning of the intestines —
including the
growth of blood vessels, the proper turnover of epithelial
cells, and the marshaling of components of the immune system needed to keep less well behaved bacteria at bay.
Auxin controls a range of responses in plants,
including cell and tissue
growth and normal development.
The device continuously monitors conditions within the microfluidic chip,
including oxygen levels, temperature, and pH, to ensure the optimum environment for
cell growth.
«This
includes the
cell division,
cell growth and the differentiation into various
cell types, such as shoots, leaves or fruit.
In addition to its known roles in cancerous
cells, STAT3 also is an essential mediator of cytokine and
growth factor signals in normal
cells that are important for diverse processes
including immunity and inflammation.
This protein is important to milk production, bone
growth, and
cell division in all animals,
including humans.
A new study just published in the journal Glia and available online on July 11th, details the newly discovered mechanism by which astrocytes are involved in inhibitory synapse formation and presents strong evidence that Transforming
Growth Factor Beta 1 (TGF β1), a protein produced by many
cell types (
including astrocytes) is a key player in this process.
Cranberries also contain a number of compounds that benefit human health —
including some that have been shown to inhibit the
growth of tumor
cells — and sequencing work may reveal more about them.
On the safety side, the panelists delved into the possible risks of injecting genetically modified
cells into patients,
including the potential for deadly viral infections, brain toxicity, and, paradoxically, the
growth of new tumors brought about by CAR - T
cells years after treatment.
«Never before has PTK6 inhibition been shown to inhibit
growth and induce
cell death of ER + breast cancer
cells,
including those resistant to standard treatments for this subtype such as tamoxifen,» said Hanna Irie, MD, PhD, Assistant Professor of Medicine (Hematology and Medical Oncology) and Oncological Sciences at The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, and senior author of the study.
Rao's team used various approaches,
including assays of telomerase activity, measurement of
cell growth, and gene expression profiling of TSY - 1 treated
cells, to determine how it acts.
Previous research has described at least some of the fundamental processes involved in healthy, on - going peripheral nerve
growth regeneration,
including the critical role of mitochondria — cellular organelles that produce adenosine triphosphate (ATP), the energy - carrying molecule found in all
cells that is vital to driving nerve recovery after injury.
Several drugs, some used clinically today, have been found to be effective in regulating the
growth of neural stem
cells,
including cancer
cells
A third class transfers the SNOs to additional proteins that control numerous additional cellular functions,
including growth, movement and metabolism, and also protect
cells from injury.
The goal of this type of therapy is to block the male hormones,
including testosterone, from stimulating the
growth of the prostate cancer
cells.
The researchers,
including scientists from pharmaceutical company AstraZeneca, report in an advanced online publication in Nature Medicine on May 4, that their findings indicate «an underappreciated genomic heterogeneity» in mechanisms of resistance to tyrosine kinase inhibitor (TKI) drugs that target the Epidermal
Growth Factor Receptor (EGFR) mutation that drive some cases of non-small
cell lung cancer (NSCLC).
The differentiation of stem
cells is largely controlled by external cues,
including morphogenic
growth factors, in the three - dimensional environment that surrounds the
cells.
These
include strengthening our biochemical resistance to stress and promoting the
growth of new brain
cells.
In vitro studies on self - inactivating vectors,
including a recent paper by this group comparing the
growth of
cells treated with their new vector and the old one, are boosting confidence.
«We can use this
cell -
growth test to select for a lot of things —
including the discovery of antibodies with potential medical uses — but Dr. Lerner and I wanted a more direct and generally applicable way of selecting for antibody function,» Zhang said.
These
include: acid hydrolysis and monosaccharide composition using gas - liquid chromatography [3], microscopic observation of xylem stem sections [4, 5], seedling
growth on medium containing
cell wall hydrolyzing enzymes [6] and Fourier - Transform Infrared (FT - IR) microspectroscopy [7, 8].
These
include, for example, the mechanisms behind stem -
cell development and what happens when normal cellular
growth spirals out of control, such as in cancer.
Other factors will also impact the evolution of adhesion phenotypes,
including the relative advantage of highly - adhesive
cells against less - adhesive
cells in direct competition [54], and the trade - off between competitive surface adhesion and the ability to disperse to new habitats for later
growth [38, 40, 83].
GPCRs and their downstream signaling are involved in cancer
growth and development by controlling many features of tumorigenesis,
including immune
cell - mediated functions, proliferation, invasion and survival at the secondary site.
Asterias maintains an extensive global intellectual property portfolio
including broad issued claims to fundamental platform technologies
including, but not limited to, scalable
growth of pluripotent stem
cells, methods of production and compositions of matter for several hESC - derived therapeutic
cell types, and cellular immunotherapy using the telomerase antigen.
These
include the Ras
cell -
growth proteins, mutated versions of which are among the most common and relentless drivers of several kinds of cancer.
These processes
included dust deposition, and ocean acidification and warming, which were shown to have a significant impact on oceanic phytoplankton
growth,
cell size and primary productivity, biological N2 fixation, phytoplankton distribution and community composition.
Through its various targets, MMP1 promotes not only tumor invasion but also breast cancer colonization to bone by mechanisms that
include the release of membrane - bound EGF - like
growth factors from tumor
cells, leading to activation of EGF receptor signaling and suppression of OPG expression in osteoblasts, which in turn promotes the differentiation and activation of osteoclasts required for bone destruction and enhanced tumor
growth in the bone microenvironment (32).
Independent of MMP activity, TIMP - 1 can promote
growth and inhibit apoptosis through various pathways,
including P13K and PKA [9] and, furthermore, TIMP - 1 is able to provide β
cell - specific pro-survival effects [5, 6, 10].
These factors
include chemokine (C - X-C motif) ligand 12 (CXCL12), a chemokine produced by bone marrow mesenchymal
cells that functions as a chemoattractant and survival factor for
cells bearing the chemokine (C - X-C motif) receptor 4 (CXCR4), and insulin - like
growth factor 1 (IGF - 1), a factor that is stored in the bone matrix and released during osteolysis (28).
Preparation and distribution of 19 reference antigens for several diseases
including malaria, HIV and tuberculosis, and the establishment of five new
cell banks to improve the
growth of adenoviral vectors.
Evidence demonstrating its cytostatic activity
includes the finding that it inhibits the
growth of a broad spectrum of human tumor
cell lines in vitro.
His research interests
include the biology of papillomaviruses and the regulation of normal and neoplastic
cell growth.
Areas of research
include biochemical and cellular mechanisms, muscle contractility and
cell motility, the genetic control of
cell growth and differentiation, and tissue damage and regeneration.
The current findings could provide important clues to determine the culture conditions for promoting the differentiation of primate ES
cells into mature gametes, and to understand molecular mechanisms of primate gametogenesis
including the timing of germ
cell induction, the regulation of germ
cell gene expression, and the response to
growth factors for germ
cell differentiation.
ES
cell generation will
include the isolation of the inner
cell mass and subsequent
growth of ES
cells from blastocysts obtained from five to ten superovulated females.
Important features of XMRV biology
include (1) tropism for a variety of
cell lines,
including prostate cancer DU145 and LNCaP
cells [27], [43], [48], and human neural
cell types [57], (2) adaptations that promote
growth in prostate epithelium and human - derived prostate cancer
cell lines
including an androgen response element in the promoter region [58] and downregulation of APOBEC3G [59], and (3) cellular effects with potential oncogenic properties
including increased tumor aggressiveness mediated by downregulation of p27 [60] and differential regulation of several microRNAs [61].
We showed that WDR47 shares functional characteristics with LIS1 and participates in key microtubule - mediated processes,
including neural stem
cell proliferation, radial migration, and
growth cone dynamics.
Specifically, the team hypothesizes that microRNA miR - 24 is a key regulator of actin cytoskeleton dynamics (i.e. the inner structural support of a
cell); therefore, it plays a critical role in regulating multiple disease processes,
including the angiogenesis (blood vessel
growth), inflammation, and fibrosis (thickening and scarring of tissue) associated with choroidal neovascularization (CNV) in wet AMD.
This
includes identifying pancreatic cancer stem
cells, the small number of
cells within a tumor that fuel its
growth and spread.